Business Context and Reporting Period
Company: The Clorox Company (CLX)
Filing Type: Form 8-K (Current Report)
Date of Report: January 17, 2026 (Event Date: January 22, 2026)
Context: The filing discloses the entry into a definitive agreement to acquire GOJO Industries, Inc., the maker of PURELL, and reaffirms the company's fiscal year 2026 financial outlook.
Key Financial Metrics and Transaction Details
- Transaction Value: $2.25 billion in cash.
- Anticipated Tax Benefits: Approximately $330 million (included in the purchase price context).
- Financing Method: Primarily through debt financing.
- Current Financial Metrics: The filing text does not provide specific current period revenue, profit, cash flow, or margin figures; it only references the reaffirmation of the fiscal 2026 outlook.
- Liquidity and Debt: Specific post-transaction debt levels and liquidity ratios are not quantified in this text, though the company notes the transaction will be funded by debt.
Material Changes and Strategic Moves
The primary material change is the strategic acquisition of GOJO Industries. This move is intended to diversify Clorox's portfolio of brands and business mix. The transaction is subject to regulatory approval and other customary closing conditions. No other material changes to historical financial performance are detailed in this specific filing.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Fiscal 2026 Outlook: Management has reaffirmed its full-year fiscal 2026 outlook for net sales, diluted EPS, and adjusted EPS.
- Expected Benefits: Management anticipates margin expansion and adjusted earnings per share accretion from the acquisition, alongside growth potential from a more diversified portfolio.
Risks and Contingencies
The filing outlines extensive risks associated with the acquisition and general operations, including:
- Transaction Risks: Failure to obtain regulatory approval, inability to meet closing conditions, integration challenges, and failure to realize anticipated synergies.
- Financial Risks: Increased indebtedness, potential decline in credit ratings, and higher cost of capital.
- Operational Risks: Disruption to ongoing business, diversion of management time, and retention of key personnel.
- Macro Risks: Inflation, supply chain disruptions, geopolitical tensions (Middle East, Ukraine, China/Taiwan), trade policy shifts, and raw material cost volatility.
Investor Verification Checklist
- Verify the specific terms of the debt financing to be used for the $2.25 billion acquisition.
- Confirm the timeline and status of required regulatory approvals for the GOJO acquisition.
- Review the detailed fiscal 2026 outlook figures (Net Sales, Diluted EPS, Adjusted EPS) referenced in the attached press release (Exhibit 99.1).
- Assess the impact of the increased leverage on Clorox's credit rating and cost of capital.
- Monitor integration plans and the realization of the projected $330 million in tax benefits.